share_log

艾美疫苗：(經修訂) 截至二零二三年十二月三十一日止之股份發行人的證券變動月報表

AIM VACCINE: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

香港交易所 ·  Apr 3 04:38
Summary by Moomoo AI
艾美疫苗股份有限公司於2024年4月3日重新提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的H股和內資股股份數量在該月份未有變動，H股結存為492,173,711股，內資股結存為718,888,888股，股份總額維持在1,211,062,599人民幣。此外，根據公司2020年11月30日採納並於2022年2月16日修訂的首次公開發售前僱員股份激勵計劃，本月底結存的股份期權數目為10,920,000股，且本月內未有新股份發行。公司確認所有證券發行均已獲董事會批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
艾美疫苗股份有限公司於2024年4月3日重新提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的H股和內資股股份數量在該月份未有變動，H股結存為492,173,711股，內資股結存為718,888,888股，股份總額維持在1,211,062,599人民幣。此外，根據公司2020年11月30日採納並於2022年2月16日修訂的首次公開發售前僱員股份激勵計劃，本月底結存的股份期權數目為10,920,000股，且本月內未有新股份發行。公司確認所有證券發行均已獲董事會批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
EMERY VACCINES CO., LTD. REFILED ON APRIL 3, 2024 ITS REPORT OF MONTHLY CHANGES IN SECURITIES FOR THE YEAR ENDED DECEMBER 31, 2023. The report showed that the company's number of H shares and equity shares remained unchanged during the month, with 492,173,711 shares outstanding and 718,888,888 shares outstanding, and the total amount of shares held at RMB 1,211,062,599. IN ADDITION, UNDER THE COMPANY'S INITIAL PUBLIC OFFERING PRE-SALE EMPLOYEE SHARE INCENTIVE PLAN ADOPTED ON NOVEMBER 30, 2020 AND AMENDED ON FEBRUARY 16, 2022, THE NUMBER OF SHARE OPTIONS OUTSTANDING AT THE END OF THE MONTH WAS 10,920,000 SHARES AND NO NEW SHARES WERE ISSUED DURING THE MONTH. The Company confirms that all securities issues have been approved by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
EMERY VACCINES CO., LTD. REFILED ON APRIL 3, 2024 ITS REPORT OF MONTHLY CHANGES IN SECURITIES FOR THE YEAR ENDED DECEMBER 31, 2023. The report showed that the company's number of H shares and equity shares remained unchanged during the month, with 492,173,711 shares outstanding and 718,888,888 shares outstanding, and the total amount of shares held at RMB 1,211,062,599. IN ADDITION, UNDER THE COMPANY'S INITIAL PUBLIC OFFERING PRE-SALE EMPLOYEE SHARE INCENTIVE PLAN ADOPTED ON NOVEMBER 30, 2020 AND AMENDED ON FEBRUARY 16, 2022, THE NUMBER OF SHARE OPTIONS OUTSTANDING AT THE END OF THE MONTH WAS 10,920,000 SHARES AND NO NEW SHARES WERE ISSUED DURING THE MONTH. The Company confirms that all securities issues have been approved by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more